Advanced in Breast Cancer in Men

Dr. Elizabeth C. Riley

Hematology Oncology | Hematology | Oncology
University Of Louisville Physicians Inc
401 E Chestnut St, 
Louisville, KY 
Accepting New Patients
Advanced in Breast Cancer in Men
University Of Louisville Physicians Inc
401 E Chestnut St, 
Louisville, KY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Elizabeth Riley is a Hematologist Oncology specialist and a Hematologist in Louisville, Kentucky. Dr. Riley is rated as an Advanced provider by MediFind in the treatment of Breast Cancer in Men. Her top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Breast Cancer, and Paget Disease of the Breast. Dr. Riley is currently accepting new patients.

Her clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 1 clinical trial in the study of Breast Cancer in Men.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in MA
Hospital Affiliations
University Of Louisville Hospital
Norton Hospitals, Inc
UOFL HEALTH - JEWISH HOSPITAL And Mary & Elizabeth Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

UNIVERSITY OF LOUISVILLE PHYSICIANS INC
401 E Chestnut St, Louisville, KY 40202

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Single Arm, Open Label Phase 2 Study of Tucatinib in Combination With Trastuzumab Deruxtecan in Subjects With Previously Treated Unresectable Locally-Advanced or Metastatic HER2+ Breast Cancer
A Single Arm, Open Label Phase 2 Study of Tucatinib in Combination With Trastuzumab Deruxtecan in Subjects With Previously Treated Unresectable Locally-Advanced or Metastatic HER2+ Breast Cancer
Enrollment Status: Completed
Publish Date: September 30, 2025
Intervention Type: Drug
Study Drugs: tucatinib, trastuzumab deruxtecan
Study Phase: Phase 2
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
An Open-Label, Randomized, Multicenter Study Evaluating the Activity of Lasofoxifene Relative to Fulvestrant for the Treatment of Pre- and Postmenopausal Women With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
An Open-Label, Randomized, Multicenter Study Evaluating the Activity of Lasofoxifene Relative to Fulvestrant for the Treatment of Pre- and Postmenopausal Women With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Enrollment Status: Active_not_recruiting
Publish Date: April 18, 2024
Intervention Type: Drug
Study Drugs: Lasofoxifene, Fulvestrant
Study Phase: Phase 2
Extended Interval Port Flushes: A Phase II Clinical Trial
Extended Interval Port Flushes: A Phase II Clinical Trial
Enrollment Status: Completed
Publish Date: July 19, 2021
Intervention Type: Other
Study Phase: Phase 2
A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel in Subjects With Advanced Breast Cancer
A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel in Subjects With Advanced Breast Cancer
Enrollment Status: Completed
Publish Date: February 01, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Predicting Adverse Cardiac Events in Breast Cancer Therapy (PACE in Breast Cancer)
Predicting Adverse Cardiac Events in Breast Cancer Therapy (PACE in Breast Cancer)
Enrollment Status: Completed
Publish Date: February 19, 2018
Intervention Type: Other, Procedure, Genetic, Biological, Drug
View 5 Less Clinical Trials
Similar Doctors
Advanced in Breast Cancer in Men
Dr. Jeffrey B. Hargis
Hematology Oncology | Hematology | Oncology
Advanced in Breast Cancer in Men
Dr. Jeffrey B. Hargis
Hematology Oncology | Hematology | Oncology

Norton Hospitals Inc

315 E Broadway, Fl 4, 
Louisville, KY 
 (0.2 miles away)
502-272-5165
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jeffrey Hargis is a Hematologist Oncology specialist and a Hematologist in Louisville, Kentucky. Dr. Hargis is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer in Men. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Hargis is currently accepting new patients.

Advanced in Breast Cancer in Men
Dr. Renato V. Larocca
Oncology
Advanced in Breast Cancer in Men
Dr. Renato V. Larocca
Oncology
315 E Broadway, 
Louisville, KY 
 (0.2 miles away)
502-629-2500
Languages Spoken:
English, Italian
See accepted insurances
Accepting New Patients

Renato Larocca is an Oncologist in Louisville, Kentucky. Dr. Larocca is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer in Men. His top areas of expertise are Astrocytoma, Embryonal Tumor with Multilayered Rosettes, Neuroepithelioma, and Atypical Teratoid Rhabdoid Tumor (ATRT). Dr. Larocca is currently accepting new patients.

Experienced in Breast Cancer in Men
Dr. Patrick A. Williams
Oncology | Hematology Oncology | Hematology
Experienced in Breast Cancer in Men
Dr. Patrick A. Williams
Oncology | Hematology Oncology | Hematology

Flaget Healthcare Inc

4359 New Shepherdsville Rd, Unit 100, 
Bardstown, KY 
 (29.2 miles away)
502-350-5700
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Patrick Williams is an Oncologist and a Hematologist Oncology provider in Bardstown, Kentucky. Dr. Williams is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer in Men. His top areas of expertise are Lung Cancer, Chronic Lymphocytic Leukemia (CLL), Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Williams is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Riley's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 32 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile